home All News open_in_new Full Article

Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced it has entered into an exclusive worldwide licensing agreement with Debiopharm International S.A. (“Debiopharm”), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, for lunresertib, […]


today 8 h. ago attach_file Other

attach_file Culture
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Other
attach_file Events
attach_file Culture
attach_file Economics
attach_file Other
attach_file Culture
attach_file Other
attach_file Economics
attach_file Other
attach_file Culture
attach_file Other
attach_file Events
attach_file Culture
attach_file Sport
attach_file Culture
attach_file Events


ID: 2465637622
Add Watch Country

arrow_drop_down